Advanced search
Publication Cover
Journal of Medical Economics Volume 15, 2012 - Issue 4
Submit an article Journal homepage
711
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Exenatide BID and liraglutide QD treatment patterns among type 2 diabetes patients in Germany

Lesley-Ann MillerEli Lilly and Company Indianapolis, INUSA
,
Chakkarin BurudpakdeeIMS Health Incorporated Falls Church, VAUSA
,
Anthony ZagarEli Lilly and Company Indianapolis, INUSA
,
Monali BhosleIMS Health Incorporated Falls Church, VAUSA
,
Matthew ReaneyEli Lilly and Company Windlesham, SurreyUKCorrespondence[email protected]
,
Vernon F. SchabertIMS Health Incorporated Falls Church, VAUSA
&
David BruhnEli Lilly and Company Indianapolis, INUSA
 show all
Pages 746-757 | Accepted 22 Mar 2012, Published online: 03 Apr 2012

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Thorsten Otto, Melissa Myland, Heike Jung, Jeremie Lebrec, Hartmut Richter & Kirsi Norrbacka. (2019) Utilization patterns of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus in Germany: a retrospective cohort study. Current Medical Research and Opinion 35:5, pages 893-901.
Read now

Articles from other publishers (7)

Victoria Divino, Kristina S. Boye, Jeremie Lebrec, Mitch DeKoven & Kirsi Norrbacka. (2019) GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims Data. Diabetes Therapy 10:3, pages 1067-1088.
Crossref
Marco Orsini Federici, Janette McQuillan, Giovanni Biricolti, Serena Losi, Jeremie Lebrec, Catrina Richards, Cristiana Miglio & Kirsi Norrbacka. (2018) Utilization Patterns of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus in Italy: A Retrospective Cohort Study. Diabetes Therapy 9:2, pages 789-801.
Crossref
Hiep Nguyen, Robert Dufour & Amanda Caldwell-Tarr. (2017) Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Therapy Adherence for Patients with Type 2 Diabetes in a Medicare Population. Advances in Therapy 34:3, pages 658-673.
Crossref
Victoria Divino, Mitch DeKoven, Farhad Ali Khan, Kristina S. Boye, Hélène Sapin & Kirsi Norrbacka. (2017) GLP-1 RA Treatment Patterns Among Type 2 Diabetes Patients in Five European Countries. Diabetes Therapy 8:1, pages 115-128.
Crossref
Sheena Kayaniyil, Greta Lozano-Ortega, Heather A. Bennett, Kristina Johnsson, Alka Shaunik, Susan Grandy & Bernt Kartman. (2016) A Network Meta-analysis Comparing Exenatide Once Weekly with Other GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus. Diabetes Therapy 7:1, pages 27-43.
Crossref
Victoria Divino, Mitch DeKoven, Shawn Hallinan, Nebibe Varol, Sara Bruce Wirta, Won Chan Lee & Matthew Reaney. (2014) Glucagon-Like Peptide-1 Receptor Agonist Treatment Patterns Among Type 2 Diabetes Patients in Six European Countries. Diabetes Therapy 5:2, pages 499-520.
Crossref
Paul L. McCormack. (2014) Exenatide Twice Daily: A Review of Its Use in the Management of Patients with Type 2 Diabetes Mellitus. Drugs 74:3, pages 325-351.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.